The potential for liquid biopsies in the precision medical treatment of breast cancer

Currently the clinical management of breast cancer relies on relatively few prognostic/predictive clinical markers (estrogen receptor, progesterone receptor, HER2), based on primary tumor biology. Circulating biomarkers, such as circulating tumor DNA (ctDNA) or circulating tumor cells (CTCs) may enh...

Descripción completa

Detalles Bibliográficos
Autores principales: Forte, Victoria A., Barrak, Dany K., Elhodaky, Mostafa, Tung, Lily, Snow, Anson, Lang, Julie E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Anti-Cancer Association 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850125/
https://www.ncbi.nlm.nih.gov/pubmed/27144060
http://dx.doi.org/10.28092/j.issn.2095-3941.2016.0007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850125/
https://www.ncbi.nlm.nih.gov/pubmed/27144060
http://dx.doi.org/10.28092/j.issn.2095-3941.2016.0007

Ejemplares similares